Fred Hite

This profile gathers the share dealings of Fred Hite in Orthopediatrics Corp, where the filings describe the role as finance chief. We count 11 filings; the first trade dates from 2 September 2021 and the latest from 15 March 2026.

Market trades split into 1 purchase (€85k) and 5 sales (€979k). The net balance comes to €894k on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 5 share grants.

The latest filing, published on 17 March 2026, reports a share grant in Orthopediatrics Corp. The last purchase on record was published on 25 August 2025, which is 419 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.